Nab-paclitaxel Compared With Docetaxel in the Neoadjuvant Chemotherapy Breast Cancer
Clinical trial NCT05251766 · UNKNOWN
Trial details
- NCT number
- NCT05251766
- Sponsor
- Xuli Meng
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-20
- Primary completion
- 2022-12-30
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.